DeFi Development Corp. is pivoting to a Solana-centric treasury operator, emphasizing Solana per share as anchor metric. Read ...

The clinical trial ecosystem is entering a phase of consolidation and reinvention driven by the collapse of boundaries between functions, data, and even companies themselves.

Biopharma enters 2026 amid continuing scientific progress and accelerating deal activity, yet its business model is under pressure across every facet of the value chain. Investors are taking note: ...

CDMOs are re-evaluating a reliance on China and increasingly turning to nearshoring and friendshoring for supply chain ...

CEO Michael Intrator has recently extended his defense in CoreWeave’s adoption of a six-year useful life on its GPU assets.

A CDMO championing a commitment to patients may sound like lip service or branding, but truly patient-centric CDMOs offer ...

A massive Amazonian fish yields the unique and once overlooked leather prized by luxury brands and Texas cowboys.

As global automotive manufacturers intensify efforts to reduce lifecycle emissions and source sustainable materials, European ...

Consultancies continue to focus on modernizing the wrong things.

As the robotics industry accelerates its transition toward large-scale commercialization, Shoucheng Holdings (0697.HK) has announced another significant milestone in its robotics investment and ...

From our work with enterprises across every major industry, a clear divide is emerging. One side will remain in business.

Food logistics is the Middle East’s most exposed supply chain, where import reliance, cold chain fragility and climate-driven ...